| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.42M | 49.19M | 20.29M | 19.63M | 16.59M | 14.68M |
| Gross Profit | 30.71M | 23.49M | 13.62M | 12.28M | 10.52M | 10.07M |
| EBITDA | 22.67M | 14.70M | 8.21M | 7.91M | 6.74M | 6.30M |
| Net Income | 13.33M | 8.52M | 6.05M | 6.15M | 5.16M | 5.12M |
Balance Sheet | ||||||
| Total Assets | 64.24M | 60.97M | 60.10M | 38.02M | 33.15M | 32.90M |
| Cash, Cash Equivalents and Short-Term Investments | 2.56M | 13.35M | 13.25M | 17.50M | 16.77M | 14.04M |
| Total Debt | 10.63M | 10.58M | 12.53M | 1.27M | 1.02M | 1.23M |
| Total Liabilities | 22.73M | 24.65M | 27.98M | 9.70M | 5.23M | 4.68M |
| Stockholders Equity | 40.95M | 35.77M | 31.54M | 27.73M | 27.28M | 27.48M |
Cash Flow | ||||||
| Free Cash Flow | 8.22M | 8.46M | 7.04M | 6.58M | 7.54M | 4.66M |
| Operating Cash Flow | 8.97M | 9.90M | 7.52M | 8.04M | 8.08M | 5.57M |
| Investing Cash Flow | -5.10M | -2.98M | -6.67M | -1.46M | 88.00K | -670.00K |
| Financing Cash Flow | -5.82M | -6.86M | -5.10M | -5.80M | -5.43M | -5.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £76.02M | ― | ― | 4.16% | ― | ― | |
70 Outperform | £586.02M | 68.94 | 1.56% | 1.73% | -0.18% | 11.49% | |
66 Neutral | £323.75M | 51.82 | 8.06% | 1.04% | 10.93% | 12.30% | |
64 Neutral | £75.55M | 20.32 | 23.08% | ― | -19.19% | -41.12% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £427.54M | 25.03 | ― | 2.16% | ― | ― | |
47 Neutral | £9.51M | -1.96 | -52.41% | ― | -31.21% | -292.31% |